Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Loading
Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Calendar quarter Q2 2026Earnings call Jul 28, 2026 · most recent call
INCY’s newest analyzed quarter is part of Tellvest Pro: its score, breakdown, narrative and analyst Q&A. Every prior quarter is free.
Sources. Scores: Incyte’s public earnings-call transcripts and SEC-reported results — the base band is anchored to reported GAAP revenue growth; transcript, EPS and guidance adjustments are applied separately (documented exceptions apply to a few issuers). Price: INCY daily closing prices for the trailing year; dots mark earnings calls, colored by that quarter’s score; the newest quarter’s score is part of Tellvest Pro. How to read a company earnings-call score.
The breakdown for this quarter is part of Tellvest Pro.
On August 31, 2026, Incyte announced an agreement with the U.S. Centers for Medicare & Medicaid Services to enable state Medicaid programs to access Jakafi and Jakafi XR at prices aligned with a defined group of other advanced, industrialized nations. Incyte also expects to be exempt from certain future CMS pricing mandates, including the proposed GUARD and GLOBE models. The company does not expect the agreement to affect its 2026 financial guidance or future financial outlook.
What each event means for INCY’s sentiment score is part of Tellvest Pro.
The table scrolls sideways. Swipe it, or select it and use the arrow keys.
| Quarter | Revenue | Rev YoY | EPS | EPS YoY | Op margin | Net margin | FCF |
|---|---|---|---|---|---|---|---|
| FY2024 Q4 | $1.18B | +16.3% | $1.02 | +14.6% | 25.2% | 17.1% | $364M |
| FY2025 Q1 | $1.05B | +19.5% | $0.80 | +6.7% | 20.6% | 15.0% | $263M |
| FY2025 Q2 | $1.22B | +16.5% | $2.04 | +200.0% | 25.6% | 33.3% | $26M |
| FY2025 Q3 | $1.37B | +20.0% | $2.11 | +290.7% | 31.6% | 31.1% | $545M |
| FY2025 Q4 | $1.51B | +27.8% | $1.46 | +43.1% | 25.5% | 19.9% | $521M |
| FY2026 Q1 | $1.27B | +20.9% | $1.47 | +83.8% | 25.5% | 23.8% | $359M |
| FY2026 Q2Selected | $1.67B | +37.7% | $2.81 | +37.7% | 41.7% | 35.0% | $495M |
Management-stated figures from INCY’s newest call are part of Tellvest Pro.
All prior quarters are free. How to browse earnings-call scores without Pro. How to read a company earnings-call score.
Full Pro access for 30 days when you create a free account. No credit card required.